BIO benefits from steady Clinical Diagnostics demand and international growth, but macro pressures and currency headwinds ...

Bio-Rad stock looks undervalued, boosted by its Sartorius stake, but headwinds and volatile guidance cap upside. Click here ...

Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz, ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

Upslope Capital Management, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the ...

Upslope Capital delivered a 14.8% net return in FY 2025, significantly outperforming the S&P Midcap 400 with reduced ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

The global transplant diagnostics market, valued at USD 3.9 billion in 2021, is anticipated to grow at a CAGR of 7.40%, reaching approximately USD 6.4 billion by 2028. This growth is driven by ...

Polymerase Chain Reaction Market To Reach US$31.3Bn By 2033 Persistence Market Research. EINPresswire/ -- The global polymerase chain reaction (PCR) market, integral to molecular diagnostics and life ...

According to MarketsandMarkets(TM), the Nucleic Acid Isolation and Purification Market is projected to grow from about USD 7.10 billion in 2025 to USD 10.99 billion by 2030, at a CAGR of 9.1%. Browse ...